Private equity opportunities in Japan for investors
Private equity is eyeing up the country and moving in to break apart giants. That will be great for investors, says Matthew Lynn.


The deal may still fall apart at the last minute. The government may step in to block it. Shareholders may get cold feet. But the takeover of the Japanese conglomerate Toshiba by the buyout giant Bain Capital looks close to completion.
If it happens, it will be among the largest buyouts of a listed company ever staged. It could also pave the way for a series of buyouts of Japan’s ageing, uncompetitive conglomerates, opening up a huge range of opportunities for their global competitors and for investors as well. Toshiba has a long and distinguished history stretching back to the 1870s, but it has been in trouble for years.
It has been beset by a series of accounting scandals, management upheavals and troubled takeovers, while competition in many of its main markets has been getting fiercer, which forced it to slim down and retrench. If you wanted to write a textbook on ineptly managed conglomerates, you couldn’t ask for a more perfect case study. Bain’s offer will probably come as a relief to shareholders and indeed to management, even in Japan, where takeovers, and foreign ones especially, have always been disapproved of.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
The first of a wave of deals
In itself it will be a huge deal. When, and if, a final price is agreed, Toshiba is likely to cost Bain at least $20bn, putting it in the top 20 buy-out deals of all time. So long as it has a free hand, Bain should be able to make plenty of money on that investment. Toshiba, like many Japanese companies, has a sprawling range of units, ranging from air conditioners to consumer electronics to medical equipment, office systems, and IT management. There are probably dozens of little businesses within it that just need capitalising, some fresh ideas, a burst of energy, and can suddenly be brought back to health and sold off at a big profit.
It will certainly be a lot easier to make money from Toshiba than from a business such as Morrisons, sold to private equity for a fat price last year, which is already very efficiently run and operating in a very competitive market.
The deal may well open the door to a wave of private-equity deals in Japan. If so, that will be a unique opportunity and one of the most compelling of the 2020s. Japan has lots of great businesses that are ripe for a shake-up. Sony would be a very tempting target for one of the tech giants. Toyota is one of the best carmakers in the world and its two domestic rivals, Mazda and Honda, have fantastic niches and strong reputations. Takeda has formidable drugs research ,distribution, and manufacturing in its domestic market, and would surely be a tempting acquisition for Pfizer, GlaxoSmithKline and AstraZeneca, especially if it was broken up into separate units.
Japan also has lots of vast, sprawling conglomerates of the sort that were all broken up in the US and UK 30 years ago. There are companies we have hardly heard of, such as Itochu, with a value of more than $50bn, which has six divisions from food to textiles, all of which could be knocked briskly into far better shape and then listed as separate companies, or sold off to their global rivals.
Rich pickings for investors
There are three broader opportunities that the Toshiba deal can unlock. For the giant buyout firms, Japan could open up a whole new wave of potential targets, and at precisely the time when traditional hunting grounds such as the UK and US were starting to look difficult. It will take a lot of capital – not many Japanese conglomerates will cost less than the $20bn Toshiba is likely to command – but the returns will be handsome. Second, there will be opportunities for some of the world’s biggest companies to pick up choice businesses in food, consumer goods, engineering and electronics as units get spun out of the conglomerates that controlled them. This could boost earnings and market share. And finally, there will be plenty for shareholders. If the private-equity firms rip through Japan, the market will finally start to deliver after three decades of dismal returns, and the buyout funds will be a pretty good bet as well.
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
Matthew Lynn is a columnist for Bloomberg, and writes weekly commentary syndicated in papers such as the Daily Telegraph, Die Welt, the Sydney Morning Herald, the South China Morning Post and the Miami Herald. He is also an associate editor of Spectator Business, and a regular contributor to The Spectator. Before that, he worked for the business section of the Sunday Times for ten years.
He has written books on finance and financial topics, including Bust: Greece, The Euro and The Sovereign Debt Crisis and The Long Depression: The Slump of 2008 to 2031. Matthew is also the author of the Death Force series of military thrillers and the founder of Lume Books, an independent publisher.
-
8 of the best houses for sale for around £500,000
Some of the best houses for sale for around £500,000 – from a 19th-century stone farm cottage in North Yorkshire and a two-bedroom apartment in Edinburgh’s New Town to a converted Methodist chapel in Norfolk
-
What will the unravelling of US-China trade mean for the economy?
What will a US-China decoupling mean for the global economy?
-
Two ways to tap into monopoly profits from airports
Most investors can’t get their hands on airports. Here are two ways you can
-
Fat profits: should you invest in weight-loss drugs?
The latest weight-loss treatments could transform public health and the world economy. Should you invest?
-
How investors could profit from Ramsden Holdings' four-part growth strategy
Ramsdens Holdings offers a diversified set of financial and retail services and a juicy yield, says Dr Michael Tubbs
-
How to invest in the booming insurance market
The insurance sector is experiencing rapid growth after years of stagnation. Smart investors should buy in now, says Rupert Hargreaves
-
Out of America's shadow: Why Trump's tariff chaos may be good for non-US stocks
Opinion Upending global investment and trade could benefit other countries at the expense of the US market, says Cris Sholto Heaton
-
BP's 'long, painful decline' – and why next year could be even tougher
Opinion Long-suffering shareholders in oil giant BP have been pushing for change. It won’t come soon enough, says Matthew Lynn
-
Investment trusts tap the profits in exotic and obscure global markets
Opinion Peter Walls, manager of the Unicorn Mastertrust fund, highlights three investment trusts as he shares where he'd put his money
-
Falling revenues and mounting debt spell trouble for Jumia Technologies
Struggling African e-commerce platform Jumia Technologies looks headed for the exit, says Dr Matthew Partridge.